JOHNSON & JOHNSON FRAUD SUIT
Did the maker of America's most popular pain-killing pills buy up an innovative electronic pain-killing device in order to stifle the product's development and thereby protect its own drug business? That question lies at the heart of a court battle between Johnson & Johnson and three inventors from Minnesota who sold their young company and its electronic pain reliever to the health care giant seven years ago. Last July a Federal jury in Minneapolis ruled that Johnson & Johnson had fraudulently bought the electronic painkilling product in order to quietly suppress the device and head off new competition for its drug business. The court ordered the New Brunswick, N.J., company to pay $170.4 million in damages and antitrust fines. According to Judge Miles Lord of the United States District Court in Minneapolis, the evidence before the jury indicated that Johnson & Johnson had engaged in fraud of ''the most extreme and culpable nature.''

